z-logo
open-access-imgOpen Access
Management of concomitant coronary artery disease and aortic valve stenosis in the era of transcatheter aortic valve treatment
Author(s) -
Stefano Cangemi,
Cristina Aurigemma,
Enrico Romagnoli,
Francesco Bianchini,
Piergiorgio Bruno,
Marialisa Nesta,
Francesco Burzotta,
Carlo Trani
Publication year - 2022
Publication title -
mini-invasive surgery
Language(s) - English
Resource type - Journals
ISSN - 2574-1225
DOI - 10.20517/2574-1225.2021.99
Subject(s) - medicine , concomitant , stenosis , cardiology , coronary artery disease , aortic valve stenosis , aortic valve
Severe calcific aortic stenosis (AS) and coronary artery disease (CAD) have common risk factors and are frequently encountered in the same patient in clinical practice. CAD has been reported in ≥ 50% of AS patients undergoing both surgical treatment and transcatheter aortic valve implantation (TAVI). In the last two decades, TAVI has been established as a less invasive alternative to surgery. Recently, more and more young and low surgical risk patients undergo TAVI. Despite the high prevalence of CAD in patients treated with TAVI, the management strategy of concomitant CAD in these patients remains an area of considerable uncertainty. This review provides an updated overview of the current knowledge about this topic and offers points for reflection about the best approach to use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here